Details
Stereochemistry | ACHIRAL |
Molecular Formula | Ag.F.2H3N |
Molecular Weight | 160.9276 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
N.N.[F-].[Ag+]
InChI
InChIKey=FJKGRAZQBBWYLG-UHFFFAOYSA-M
InChI=1S/Ag.FH.2H3N/h;1H;2*1H3/q+1;;;/p-1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/19278981https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+2930 | https://www.ncbi.nlm.nih.gov/pubmed/11294738https://www.ncbi.nlm.nih.gov/pubmed/26897901https://www.ncbi.nlm.nih.gov/pubmed/25781988The legal airborne permissible exposure limit (PEL) is 11 mg/m^2 averaged over an 8-hour workshift.https://www.ncbi.nlm.nih.gov/pubmed/20429870https://www.purebio.com/assets/001/5202.pdfhttp://google.com/patents/CN102923966BCurator's Comment: description was created based on several sources, including
https://encrypted.google.com/patents/WO2004093793A2
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19278981https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+2930 | https://www.ncbi.nlm.nih.gov/pubmed/11294738https://www.ncbi.nlm.nih.gov/pubmed/26897901https://www.ncbi.nlm.nih.gov/pubmed/25781988The legal airborne permissible exposure limit (PEL) is 11 mg/m^2 averaged over an 8-hour workshift.https://www.ncbi.nlm.nih.gov/pubmed/20429870https://www.purebio.com/assets/001/5202.pdfhttp://google.com/patents/CN102923966B
Curator's Comment: description was created based on several sources, including
https://encrypted.google.com/patents/WO2004093793A2
Silver Lactate Monohydrate is odorurless, gray-to-white, light-sensitive crystals, slightly soluble in water and in alcohol. Silver Lactate Monohydrate possess antimicrobial activity and can be used for the manufacture of substrates with antimicrobial activity
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20429870Vestsi Akademii Navuk BSSR, Seryya Khimichnykh Navuk, Issue 2, Pages 69-73, Journal, 1990
Curator's Comment: The medical uses of silver date back to at least the time of Hippocrates
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0071292 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18245232 |
|||
Target ID: GO:0034505 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26897901 |
|||
Target ID: GO:0071292 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18245232 |
|||
Target ID: GO:0034505 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24373700 |
|||
Target ID: GO:0071292 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18245232 |
|||
Target ID: GO:0071292 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18245232 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Advantage Arrest Silver Diamine Fluoride Approved UseUnknown |
|||
Primary | Advantage Arrest Silver Diamine Fluoride Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Curative | Unknown Approved UseUnknown |
|||
Curative | Unknown Approved UseUnknown |
|||
Primary | Colloidal silver iodide Approved UseSolution containing 5 to 49% of colloidal silver iodide have been employed in the treatment of infections of the mucous membranes. Ointments, usually containing 5%, have been used in inflammatory conditions of the eye, ear, and nose. |
|||
Primary | Colloidal silver iodide Approved UseSolution containing 5 to 49% of colloidal silver iodide have been employed in the treatment of infections of the mucous membranes. Ointments, usually containing 5%, have been used in inflammatory conditions of the eye, ear, and nose. |
|||
Palliative | Unknown Approved UseAntiseptic Wound Cauterization |
|||
Primary | Unknown Approved UseProphylaxis of gonococcal ophthalmia neonatorum. AAP recommends use of topical silver nitrate, povidone-iodine, or possibly erythromycin for prophylaxis of nongonococcal nonchlamydial conjunctivitis in neonates, ideally administered shortly after birth. |
PubMed
Title | Date | PubMed |
---|---|---|
Lack of genotoxicity of silver iodide in the SCE assay in vitro, in vivo, and in the Ames/microsome test. | 1998 |
|
A chemically intelligent antimicrobial coating for urologic devices. | 2000 Feb |
|
New disinfection and sterilization methods. | 2001 Mar-Apr |
|
Comparative efficacy of hand hygiene agents in the reduction of bacteria and viruses. | 2005 Mar |
|
An alternate technique of care using silver fluoride followed by stannous fluoride in the management of root caries in aged care. | 2016 Mar-Apr |
|
Directional growth of Ag nanorod from polymeric silver cyanide: A potential substrate for concentration dependent SERS signal enhancement leading to melamine detection. | 2017 Aug 5 |
|
The antifungal effects and mechanical properties of silver bromide/cationic polymer nano-composite-modified Poly-methyl methacrylate-based dental resin. | 2017 May 8 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24373700
Curator's Comment: Toxicity data
Lesions, without an accompanying pulp exposure were treated with a solution of 40% silver fluoride for 60 seconds. This was immediately followed by the application of a 10% stannous fluoride paste. A piece of dissolving adhesive wafer was adapted over each treatment site and then allowed to dissolve in the oral fluids. Clinical examination showed that all treated lesions had an uninterrupted black surface 24 hours after treatment.
Route of Administration:
Topical
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C28394
Created by
admin on Wed Jul 05 23:45:38 UTC 2023 , Edited by admin on Wed Jul 05 23:45:38 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C90990
Created by
admin on Wed Jul 05 23:45:38 UTC 2023 , Edited by admin on Wed Jul 05 23:45:38 UTC 2023
|
PRIMARY | |||
|
161820
Created by
admin on Wed Jul 05 23:45:38 UTC 2023 , Edited by admin on Wed Jul 05 23:45:38 UTC 2023
|
PRIMARY | |||
|
DTXSID70955992
Created by
admin on Wed Jul 05 23:45:38 UTC 2023 , Edited by admin on Wed Jul 05 23:45:38 UTC 2023
|
PRIMARY | |||
|
32129
Created by
admin on Wed Jul 05 23:45:38 UTC 2023 , Edited by admin on Wed Jul 05 23:45:38 UTC 2023
|
PRIMARY | |||
|
SUB13555MIG
Created by
admin on Wed Jul 05 23:45:38 UTC 2023 , Edited by admin on Wed Jul 05 23:45:38 UTC 2023
|
PRIMARY | |||
|
C024633
Created by
admin on Wed Jul 05 23:45:38 UTC 2023 , Edited by admin on Wed Jul 05 23:45:38 UTC 2023
|
PRIMARY | |||
|
DDU19UEV1Y
Created by
admin on Wed Jul 05 23:45:38 UTC 2023 , Edited by admin on Wed Jul 05 23:45:38 UTC 2023
|
PRIMARY | |||
|
34445-07-3
Created by
admin on Wed Jul 05 23:45:38 UTC 2023 , Edited by admin on Wed Jul 05 23:45:38 UTC 2023
|
PRIMARY | |||
|
Silver diammine fluoride
Created by
admin on Wed Jul 05 23:45:38 UTC 2023 , Edited by admin on Wed Jul 05 23:45:38 UTC 2023
|
PRIMARY | |||
|
100000079527
Created by
admin on Wed Jul 05 23:45:38 UTC 2023 , Edited by admin on Wed Jul 05 23:45:38 UTC 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD